Gritstone Bio
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2015-01-01
- Employees
- 231
- Market Cap
- $57.5M
- Website
- http://www.gritstonebio.com
- Introduction
Gritstone bio, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria in August 2015 and is headquartered in Emeryville, CA.
Study of an Individualized Vaccine Targeting Neoantigens in Combination With Immune Checkpoint Blockade for Patients With Colon Cancer
- Conditions
- Interventions
- First Posted Date
- 2022-07-13
- Last Posted Date
- 2022-11-25
- Lead Sponsor
- Gritstone bio, Inc.
- Target Recruit Count
- 1
- Registration Number
- NCT05456165
- Locations
- 🇺🇸
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States
🇺🇸Christ Hospital Cancer Center, Cincinnati, Ohio, United States
🇺🇸NYU Langone Health, New York, New York, United States
Study of Self-Amplifying Messenger Ribonucleic Acid (samRNA) Vaccines Against COVID-19 in Healthy Adults and People Living With Human Immunodeficiency Virus (HIV)
- Conditions
- Interventions
- First Posted Date
- 2022-06-28
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- Gritstone bio, Inc.
- Target Recruit Count
- 342
- Registration Number
- NCT05435027
- Locations
- 🇿🇦
Newtown Clinical Research Centre, Johannesburg, South Africa
🇿🇦WITS RHI Shandukani Research Centre, Johannesburg, South Africa
🇿🇦Setshaba Research Center, Pretoria, South Africa
A Screening Study Targeting Tumor-specific Antigens
- First Posted Date
- 2021-12-15
- Last Posted Date
- 2022-10-18
- Lead Sponsor
- Gritstone bio, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT05158621
- Locations
- 🇺🇸
Advanced Research, Tamarac, Florida, United States
🇺🇸Astera Cancer Care, East Brunswick, New Jersey, United States
🇺🇸Miami Cancer Institute, Miami, Florida, United States
Study of GRT-R910 COVID-19 Boost Vaccine in Healthy Volunteers
- First Posted Date
- 2021-12-08
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- Gritstone bio, Inc.
- Target Recruit Count
- 45
- Registration Number
- NCT05148962
- Locations
- 🇬🇧
University Hospitals Birmingham NHS, Birmingham, United Kingdom
🇬🇧University Hospital of Leicester NHS Trust, Leicester, United Kingdom
🇬🇧Manchester University, Manchester, United Kingdom
A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer
- Conditions
- Interventions
- First Posted Date
- 2021-12-02
- Last Posted Date
- 2023-12-22
- Lead Sponsor
- Gritstone bio, Inc.
- Target Recruit Count
- 700
- Registration Number
- NCT05141721
- Locations
- 🇺🇸
Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania, United States
🇺🇸Advanced Research (Oncology & Hemotology Associates of West Broward), Tamarac, Florida, United States
🇺🇸Banner MD Anderson, Gilbert, Arizona, United States
A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens
- First Posted Date
- 2019-05-16
- Last Posted Date
- 2023-09-13
- Lead Sponsor
- Gritstone bio, Inc.
- Target Recruit Count
- 39
- Registration Number
- NCT03953235
- Locations
- 🇺🇸
Mayo Clinic Florida, Jacksonville, Florida, United States
🇺🇸UCLA Medical Center, Santa Monica, California, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
A Study of Personalized Neoantigen Cancer Vaccines
- First Posted Date
- 2019-01-04
- Last Posted Date
- 2020-09-11
- Lead Sponsor
- Gritstone bio, Inc.
- Target Recruit Count
- 93
- Registration Number
- NCT03794128
- Locations
- 🇺🇸
University of Chicago Medicine Comprehensive Cancer Center, Chicago, Illinois, United States
🇺🇸The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
🇺🇸Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center, New York, New York, United States
A Study of a Personalized Neoantigen Cancer Vaccine
- First Posted Date
- 2018-08-21
- Last Posted Date
- 2023-09-13
- Lead Sponsor
- Gritstone bio, Inc.
- Target Recruit Count
- 29
- Registration Number
- NCT03639714
- Locations
- 🇦🇺
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
🇺🇸The University of Chicago, Chicago, Illinois, United States
🇺🇸The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States